3//SEC Filing
Quan Venture Fund II, L.P. 3
Accession 0001123292-19-000722
CIK 0001661059other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:04 PM ET
Size
14.3 KB
Accession
0001123292-19-000722
Insider Transaction Report
Form 3
NextCure, Inc.NXTC
Quan Venture Fund II, L.P.
10% Owner
Holdings
- (indirect: By Quan Venture Fund II, L.P.)
Series B-2 Preferred Stock
→ Common Stock (978,570 underlying)
Xu Stella
Director
Holdings
- (indirect: By Quan Venture Fund II, L.P.)
Series B-2 Preferred Stock
→ Common Stock (978,570 underlying)
Footnotes (2)
- [F1]The reported securities are convertible into shares of Common Stock on a 1-for-8.0338 basis at the holder's election, will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering, and have no expiration date.
- [F2]The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C. Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P. Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest.
Documents
Issuer
NextCure, Inc.
CIK 0001661059
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001750370
Filing Metadata
- Form type
- 3
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 8:04 PM ET
- Size
- 14.3 KB